October 8, 2020
JacobsWyper is working with Scheer Partners to understand The Curtis building's capacity for Life Sciences.
Partner Terry Jacobs, AIA, said after a recent visit with Scheer’s team, “We have extensive experience over decades working with very particular bio and pharma clients, and the spacious, 80,000 square feet Curtis floors we looked at checked
their boxes when looking for readily adaptable cGMP-compliant space.” Specifically, these features include:
Scheer Partners, the specialty scientific real estate firm that recently opened a Philadelphia office, expects The Curtis to increasingly play a leading role in meeting the comprehensive space needs of Philadelphia’s surging life sciences community, according to officials of the firm that just entered a representation agreement with Keystone Property Group, Inc., owner of the iconic building.